Pan M - Search Results

1

Reinforcing B16F10/GPI-IL-21 vaccine efficacy against melanoma by injecting mice with shZEB1 plasmid or miR200c agomir.

Wang X, Zhao F, Shi F, He X, Pan M, Wu D, Li M, Zhang Y, Dou J. Wang X, et al. Among authors: pan m. Biomed Pharmacother. 2016 May;80:136-144. doi: 10.1016/j.biopha.2016.03.013. Epub 2016 Mar 21. Biomed Pharmacother. 2016. PMID: 27133050

2

Decrease of ZEB1 expression inhibits the B16F10 cancer stem-like properties.

Zhao F, He X, Wang Y, Shi F, Wu D, Pan M, Li M, Wu S, Wang X, Dou J. Zhao F, et al. Among authors: pan m. Biosci Trends. 2015 Oct;9(5):325-34. doi: 10.5582/bst.2015.01106. Biosci Trends. 2015. PMID: 26559025 Free article.

3

Cancer stem cell vaccine expressing ESAT-6-gpi and IL-21 inhibits melanoma growth and metastases.

Zhao F, He X, Sun J, Wu D, Pan M, Li M, Wu S, Zhang R, Yan C, Dou J. Zhao F, et al. Among authors: pan m. Am J Transl Res. 2015 Oct 15;7(10):1870-82. eCollection 2015. Am J Transl Res. 2015. PMID: 26692931 Free PMC article.

4

Effective tumor immunity to melanoma mediated by B16F10 cancer stem cell vaccine.

Zhao F, Zhang R, Wang J, Wu D, Pan M, Li M, Guo M, Dou J. Zhao F, et al. Among authors: pan m. Int Immunopharmacol. 2017 Nov;52:238-244. doi: 10.1016/j.intimp.2017.09.019. Epub 2017 Sep 23. Int Immunopharmacol. 2017. PMID: 28950176

5

The surface dominant antigen MUC1 is required for colorectal cancer stem cell vaccine to exert anti-tumor efficacy.

Guo M, You C, Dong W, Luo B, Wu Y, Chen Y, Li J, Pan M, Li M, Zhao F, Dou J. Guo M, et al. Among authors: pan m. Biomed Pharmacother. 2020 Dec;132:110804. doi: 10.1016/j.biopha.2020.110804. Epub 2020 Oct 2. Biomed Pharmacother. 2020. PMID: 33017767 Free article.

6

[Effect of the immune strategy based on BCG priming and Ag85A/GM-CSF DNA vaccine boosting in mice].

Tang Q, Dou J, Zhao FS, Chu LL, Pan M, Wang YF. Tang Q, et al. Among authors: pan m. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2007 Jul;23(7):591-4. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2007. PMID: 17618574 Chinese.

7

Effect of targeted ovarian cancer immunotherapy using ovarian cancer stem cell vaccine.

Wu D, Wang J, Cai Y, Ren M, Zhang Y, Shi F, Zhao F, He X, Pan M, Yan C, Dou J. Wu D, et al. Among authors: pan m. J Ovarian Res. 2015 Oct 24;8:68. doi: 10.1186/s13048-015-0196-5. J Ovarian Res. 2015. PMID: 26497895 Free PMC article.

8

Homoharringtonine delivered by high proportion PEG of long- circulating liposomes inhibits RPMI8226 multiple myeloma cells in vitro and in vivo.

Li M, Fei X, Shi F, Dou J, Wu S, Wu D, Zhang Y, Pan M, Luo S, Gu N. Li M, et al. Among authors: pan m. Am J Transl Res. 2016 Mar 15;8(3):1355-68. eCollection 2016. Am J Transl Res. 2016. PMID: 27186264 Free PMC article.

9

PEGylated long-circulating liposomes deliver homoharringtonine to suppress multiple myeloma cancer stem cells.

Li M, Shi F, Fei X, Wu S, Wu D, Pan M, Luo S, Gu N, Dou J. Li M, et al. Among authors: pan m. Exp Biol Med (Maywood). 2017 May;242(9):996-1004. doi: 10.1177/1535370216685008. Epub 2017 Jan 1. Exp Biol Med (Maywood). 2017. PMID: 28056549 Free PMC article.

10

MiRNA-34a overexpression inhibits multiple myeloma cancer stem cell growth in mice by suppressing TGIF2.

Wu S, He X, Li M, Shi F, Wu D, Pan M, Guo M, Zhang R, Luo S, Gu N, Dou J. Wu S, et al. Among authors: pan m. Am J Transl Res. 2016 Dec 15;8(12):5433-5443. eCollection 2016. Am J Transl Res. 2016. PMID: 28078014 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,274 results

Search Page

Filters